Godoy-Matos, A. F. d., Valerio, C. M., Silva Júnior, W. S., Araujo Neto, J. M. d., & Bertoluci, M. C. (2024). 2024 UPDATE: The Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Citación estilo ChicagoGodoy-Matos, Amélio F. de, Cynthia Melissa Valerio, Wellington Santana Silva Júnior, João Marcello de Araujo Neto, y Marcello Casaccia Bertoluci. 2024 UPDATE: The Brazilian Diabetes Society Position On the Management of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in People With Prediabetes or Type 2 Diabetes. 2024.
Cita MLAGodoy-Matos, Amélio F. de, et al. 2024 UPDATE: The Brazilian Diabetes Society Position On the Management of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in People With Prediabetes or Type 2 Diabetes. 2024.